免疫球蛋白G4相关的硬化性胆道炎的内镜诊断
Itaru Naitoh1, Michihiro Yoshida2, Takahiro Nakazawa2
1Department of Gastroenterology, Nagoya City University Midori Municipal Hospital, Aichi, Japan.
概括
免疫球蛋白G4 (IgG4) 相关的硬化性胆管炎 (IgG4-SC) 诊断依赖于内镜逆行胆管细胞造影 (ERCP) 和内镜超声波 (EUS). 这些方法将IgG4-SC与类似的胆汁疾病区分开来.
科学领域:
- 胃肠病学和肝病学 胃肠学和肝病学
- 诊断成像 诊断成像 诊断成像
- 免疫学 免疫学 免疫学
背景情况:
- 免疫球蛋白G4 (IgG4) 相关的硬化性脑膜炎 (IgG4-SC) 是IgG4相关疾病的胆道表现,通常与自身免疫性胰腺炎有关.
- 准确的诊断至关重要,因为IgG4-SC可以模仿其他严重疾病,如胆管癌和原发性硬化胆管炎 (PSC).
研究的目的:
- 突出内镜技术在诊断IgG4-SC.中的关键作用.
- 使用特定的成像发现,将IgG4-SC与其他胆道狭窄区分开来.
主要方法:
- 内镜逆行胆血管细胞造影 (ERCP) 用于评估胆道狭窄和胆血管学分类.
- 内镜超声波 (EUS) 和导管内超声波 (IDUS) 用于评估胆道壁厚度.
- 胆管和十二指卵泡活检用于病理评估,不包括恶性瘤.
主要成果:
- ERCP胆血管图分为四种类型,有助于差异诊断.
- 典型的ERCP发现包括扩散性或细分性收缩,使IgG4-SC与PSC有所区别.
- IDUS显示了圆形,对称的胆道壁在狭窄和非狭窄部位的加厚.
结论:
- 内镜方式,特别是ERCP和EUS/IDUS,对于诊断IgG4-SC.不可或缺.
- 这些技术对于将IgG4-SC与PSC和胆管癌等模仿者区分开来至关重要.
- 活检具有补充作用,主要用于排除恶性瘤.
相关概念视频
01:26Endoscopic Procedures V: ERCP
37
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
Patient...
37
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
236
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
236
01:29Chronic Pancreatitis II: Collaborative Care
48
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
48
01:17Chronic Bowel Disorders: Introduction
310
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
310
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
64
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
64